Light The Night Campaign Launches a Season of Hope
The Leukemia & Lymphoma Society kicks off its philanthropic initiative, Light The Night, encouraging communities across the nation to understand the importance of awareness and support.
The Leukemia & Lymphoma Society (LLS) has officially launched its 31st annual Light The Night campaign, bringing together nearly 100 communities to advocate for an end to cancer through illuminated lantern walks. This event has become a staple of LLS’s outreach efforts since it began, garnering enthusiastic support across the U.S. each fall to raise funds for vital research and patient support services.
Understanding Blood Cancer
Blood cancer encompasses over 100 different types, impacting approximately 1.6 million individuals in the United States alone. The effects of these diseases extend beyond the patients, deeply affecting families, friends, and caregivers, making awareness and support crucial.
September: National Blood Cancer Awareness Month
September is designated as National Blood Cancer Awareness Month, encouraging communities to participate in and support local events. E. Anders Kolb, M.D., President and CEO of LLS, stresses the importance of understanding these diseases, noting that blood cancers often do not receive the same level of recognition as more widely known cancers.
Education is Key
Dr. Kolb remarked, "Blood cancer isn't often referred to as 'blood cancer,' which leads to a lack of awareness among patients. Early recognition of the signs and access to accurate information can greatly improve patient outcomes." LLS is committed to providing essential information and resources to assist patients throughout their journey.
Introducing LLS's Honored Hero
Each year, Light The Night honors a hero who shares their personal journey. This year’s hero is Ben Tappana, a brave 10-year-old survivor of acute lymphoblastic leukemia. His journey began with mysterious illnesses and persistent hip pain, ultimately leading to his diagnosis after extensive testing.
The Family's Experience
Ben’s mother reflects on this challenging time: "We were filled with fear but did our best to comfort our confused and sick little boy." After undergoing a rigorous chemotherapy regimen, Ben completed his treatment in June 2022. Now, he and his family share their story to inspire hope in others facing similar challenges.
Advocating for Change
While many children survive leukemia, it is important to acknowledge that current treatments can be harsh and outdated. LLS is at the forefront of advocating for change through initiatives like the Dare to Dream Project, which aims to transform children's cancer treatment and ensure that young patients not only survive but thrive after treatment.
The Impact of Light The Night
As one of the leading peer-to-peer fundraising programs, Light The Night has enabled LLS to invest over $1.7 billion in groundbreaking research worldwide, facilitating critical advancements in blood cancer treatments and care.
Partnerships That Make a Difference
To enhance the outreach and support of Light The Night, LLS is proud to announce its 2024 National Sponsors, featuring a mix of new and established partnerships.
Looking Forward
"LLS is incredibly thankful for our sponsors and the unwavering support from the community. Together, we are making a tangible difference in the lives of patients and families affected by blood cancer," said Coker Powell, Chief Revenue Officer of LLS. The dedication shown through these partnerships fuels hope and progress in this ongoing fight.
Get Involved with Light The Night
Community involvement is essential, and LLS invites everyone to register for a Light The Night event in their area. You can also show your support on social media by tagging @LLSusa and using the hashtag #LightTheNight.
If you need more information or wish to arrange interviews with representatives, please contact: [email protected].
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against blood cancer, dedicated to discovering cures for leukemia, lymphoma, Hodgkin's disease, and myeloma, while improving the lives of affected patients and their families. Founded in 1949 and headquartered in Rye Brook, NY, LLS invests in lifesaving research, offers free information and support services, and advocates for patient access to affordable care.
To learn more, visit www.LLS.org. For assistance, the Information Resource Center is available at (800) 955-4572, Monday to Friday, from 9 a.m. to 9 p.m. ET.
For updates, follow LLS on social media: Facebook, Twitter, Instagram, LinkedIn, and TikTok.
Frequently Asked Questions
What is the purpose of the Light The Night campaign?
The Light The Night campaign aims to raise awareness and funds for blood cancer research while providing support for patients and their families.
Who is the honored hero for this year’s event?
This year's honored hero is 10-year-old Ben Tappana, a survivor of acute lymphoblastic leukemia.
How can people get involved with Light The Night?
Individuals can participate by registering for a local event, sharing information on social media, or donating to the campaign.
How long has the Light The Night campaign been running?
The campaign has been held annually since 1993, marking its 31st anniversary this year.
What impact has LLS had on blood cancer research?
LLS has invested over $1.7 billion globally in blood cancer research, contributing to significant advancements in treatments and care.
